1. 1356PThe level of circulating NKp46+ CD56dim CD16+ natural killer cells predicts distinct survival in non-small cell lung cancer. (23rd October 2018) Authors: Picard, E; Godet, Y; Laheurte, C; Boullerot, L; Lauret Marie Joseph, E; Jacquin, M; Kaulek, V; Eberst, G; Gaugler, B; Jacoulet, P; Gainet-Brun, M; Lahoucarde, J; Almotlak, H; Le Pimpec-Barthes, F; Fabre-Guillevin, E; Borg, C; Westeel, V; Adotevi, O Journal: Annals of oncology Issue: Volume 29(2018)Supplement 8 Page Start: Record Type: Journal Article View Content: Available online (eLD content is only available in our Reading Rooms) ↗
2. 40PInterest and potential of genetically engineered cord blood derived T cells for cancer immunotherapy. (17th December 2018) Authors: Marton, C; Mercier-Letondal, P; Deschamps, M; Ferrand, C; Adotevi, O; Borg, C; Galaine, J; Godet, Y Journal: Annals of oncology Issue: Volume 29(2018)Supplement 10 Page Start: Record Type: Journal Article View Content: Available online (eLD content is only available in our Reading Rooms) ↗
3. 92PUnderstanding the anti-tumor T cell responses modulation mediated by chemoradiation to improve immunotherapy efficacy. (17th December 2018) Authors: Lauret, E; Bonin, C; Rangan, L; Boullerot, L; Boustani, J; Fagnoni-Legat, C; Perrin, S; Mirjolet, C; Dosset, M; Boidot, R; Servagi, S; De Bari, B; Adotevi, O Journal: Annals of oncology Issue: Volume 29(2018)Supplement 10 Page Start: Record Type: Journal Article View Content: Available online (eLD content is only available in our Reading Rooms) ↗